Apixaban compared with warfarin in patients with atrial fibrillation and previous stroke or transient ischaemic attack: a subgroup analysis of the ARISTOTLE trial
The Lancet Neurology,  Clinical Article

Easton JD et al. – The effects of apixaban versus warfarin were consistent in patients with atrial fibrillation (AF) with and without previous stroke or transient ischaemic attack (TIA). Owing to the higher risk of these outcomes in patients with previous stroke or TIA, the absolute benefits of apixaban might be greater in this population.

Methods
  • Between Dec 19, 2006, and April 2, 2010, patients were enrolled in the ARISTOTLE trial at 1034 clinical sites in 39 countries.
  • 18 201 patients with AF or atrial flutter were randomly assigned to receive apixaban 5 mg twice daily or warfarin (target international normalised ratio 2•0–3•0).
  • The median duration of follow–up was 1•8 years (IQR 1•4–2•3).
  • The primary efficacy outcome was stroke or systemic embolism, analysed by intention to treat.
  • The primary safety outcome was major bleeding in the on–treatment population.
  • All participants, investigators, and sponsors were masked to treatment assignments.
  • In this subgroup analysis, authors estimated event rates and used Cox models to compare outcomes in patients with and without previous stroke or TIA.

Results
  • Of the trial population, 3436 (19%) had a previous stroke or TIA.
  • In the subgroup of patients with previous stroke or TIA, the rate of stroke or systemic embolism was 2•46 per 100 patient–years of follow–up in the apixaban group and 3•24 in the warfarin group (hazard ratio [HR] 0•76, 95% CI 0•56 to 1•03); in the subgroup of patients without previous stroke or TIA, the rate of stroke or systemic embolism was 1•01 per 100 patient–years of follow–up with apixaban and 1•23 with warfarin (HR 0•82, 95% CI 0•65 to 1•03; p for interaction=0•71).
  • The absolute reduction in the rate of stroke and systemic embolism with apixaban versus warfarin was 0•77 per 100 patient–years of follow–up (95% CI –0•08 to 1•63) in patients with and 0•22 (–0•03 to 0•47) in those without previous stroke or TIA.
  • The difference in major bleeding with apixaban compared with warfarin was 1•07 per 100 patient–years (95% CI 0•09–2•04) in patients with and 0•93 (0•54–1•32) in those without previous stroke or TIA.

Please login or register to follow this author.
► Click here to access PubMed, Publisher and related articles...
<< Previous Article | Next Article >>

Your Unread Messages in Nurse Practitioner

See All >> Messages include industry-sponsored communications and special communications from MDLinx

Most Popular Nurse Practitioner Articles

1 Chocolate intake and diabetes risk Clinical Nutrition, October 27, 2014    Clinical Article

2 Effects of serum zinc level on tinnitus American Journal of Otolaryngology, December 5, 2014    Clinical Article

3 Role of vitamin D deficiency in male fertility Fertility and Sterility, January 22, 2015    Clinical Article

4 Tea and coffee and risk of endometrial cancer: cohort study and meta-analysis American Journal of Clinical Nutrition, January 23, 2015    Clinical Article

5 Association of tea consumption and the risk of oral cancer: A meta-analysis Oral Oncology , January 10, 2014    Evidence Based Medicine

6 Green tea consumption and the risk of the related factors of cardiovascular diseases and ischemic related diseases: A meta-analysis International Journal of Cardiology, January 12, 2015    Evidence Based Medicine    Review Article

7 Effects of combined vitamin D - calcium supplements on the cardiovascular system: should we be cautious Atherosclerosis, January 2, 2015    Clinical Article

8 Association of daily coffee and tea consumption and metabolic syndrome: results from the Polish arm of the HAPIEE study European Journal of Nutrition, November 21, 2014    Clinical Article

9 Chocolate consumption and risk of diabetes mellitus in the Physicians’ Health Study American Journal of Clinical Nutrition, December 10, 2014    Review Article

10 Effects of regular consumption of different forms of almonds and hazelnuts on acceptance and blood lipids European Journal of Nutrition, December 12, 2014    Clinical Article

11 Consumption of fruit and vegetable and risk of coronary heart disease: a meta-analysis of prospective cohort studies International Journal of Cardiology, January 29, 2015    Evidence Based Medicine    Review Article

12 Soy and isoflavone consumption and risk of gastrointestinal cancer: a systematic review and meta-analysis European Journal of Nutrition, January 6, 2015    Evidence Based Medicine    Review Article

13 The role of vitamin D in osteoporosis Maturitas, January 30, 2015    Clinical Article

14 Association between dietary fiber and lower risk of all-cause mortality: a meta-analysis of cohort studies American Journal of Epidemiology, January 9, 2015    Evidence Based Medicine    Review Article    Clinical Article

15 The use of art and music therapy in substance abuse treatment programs Journal of Addictions Nursing, January 8, 2015

16 Red meat intake, NAT2, and risk of colorectal cancer: a pooled analysis of 11 studies Cancer Epidemiology, Biomarkers & Prevention, January 2, 2015    Clinical Article

17 Coffee for morning hunger pangs. An examination of coffee and caffeine on appetite, gastric emptying, and energy intake Appetite, October 17, 2014    Clinical Article

18 n–3 Long-chain PUFAs reduce respiratory morbidity caused by iron supplementation in iron-deficient South African schoolchildren: a randomized, double-blind, placebo-controlled intervention American Journal of Clinical Nutrition, January 9, 2015    Clinical Article

19 Calcium ingestion suppresses appetite and produces acute overcompensation of energy intake independent of protein in healthy adults The Journal of Nutrition, January 23, 2015    Clinical Article

20 Association of urinary calcium excretion with serum calcium and Vitamin D levels Clinical Journal of the American Society of Nephrology, January 2, 2015    Clinical Article

Indexed Journals in Nurse Practitioner: Journal of the American Academy of Nurse Practitioners, Holistic Nursing Practicemore

Looking for a physician job? Let us help!

Register now for our free job placement service.
A career consultant will contact you soon.
Click Here for more information.

Get Started Now!

Free-of-charge, no obligation.

Terms and Conditions For M3 Career Consult

By registering with the M3 Career Consult service you authorize M3 USA Corporation to represent you in your job search. The following is a summary of the terms of our service and our mutual obligations to help you find a job:

  • You designate M3 to act as your agent and represent you in your job search;
  • You will not pay us for this service
  • You will advise us of any companies or positions to which you apply or have applied;
  • You will advise us if you believe you are not capable of performing a position for which we submit you, or for which you interview;
  • You will keep all information we provide you about companies or positions strictly confidential;
  • You will promptly provide us with information we request of you;
  • You will make yourself reasonably available for phone, video and in-person conversations and interviews;
  • You will be truthful in all of your communications with us; and
  • You will advise us if anything above changes.
 

The Top Read Articles of 2014 are Now Available

Scouring thousands of peer-reviewed journals and popular press, Our Editors just released the Top Read Articles of the Year. See the Top Read List